2009
DOI: 10.1016/j.jaci.2009.01.068
|View full text |Cite
|
Sign up to set email alerts
|

A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome

Abstract: A novel mutation in the linker domain of the signal transducer and activator of transcription 3 gene, p.Lys531Glu, in hyper-IgE syndrome To the Editor:Hyper-IgE syndrome (HIES) is a rare primary immunodeficiency disorder characterized by eczema, recurrent abscesses, pneumonia with pneumatocele, and an increased serum IgE level. Most cases are sporadic, but both autosomal dominant and autosomal recessive forms have been described. 1 Recently, mutations in the signal transducer and activator of transcription fac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 8 publications
1
13
0
1
Order By: Relevance
“…As discussed above, I568F is a HIES associated mutation in the LD 25; 26 . Coincidently, I568 undergoes the largest changes in structure and dynamics among all measured residues when the SH2 domain forms a complex with a pTyr-containing peptide (Figs.…”
Section: Resultsmentioning
confidence: 91%
See 1 more Smart Citation
“…As discussed above, I568F is a HIES associated mutation in the LD 25; 26 . Coincidently, I568 undergoes the largest changes in structure and dynamics among all measured residues when the SH2 domain forms a complex with a pTyr-containing peptide (Figs.…”
Section: Resultsmentioning
confidence: 91%
“…Further investigation of the role of allostery in STAT function is needed, because currently available X-ray structures of STAT proteins do not provide sufficient understanding of the mechanisms underlying the conditions caused by some recently identified disease-inducing mutations 5 . Aberrantly weakened STAT3 signaling due to mutations are linked to various diseases including the hyper immunoglobulin E syndrome (HIES) 6; 7 .…”
Section: Introductionmentioning
confidence: 99%
“…We have confirmed that these mutations are located at mutation hotspots. [28,29,33,47,55,60,62,70,71] Exons 13, 16, and 21---in which these mutations are located---could thus be sequenced first, in cases of suspected STAT3 deficiency. An impairment of STAT3 phosphorylation and STAT3 translocation to the nucleus and DNA-binding were found in EBV-B cell lines from 9 patients bearing 5 previously identified heterozygous mutations (R382W, R382Q, T412S, Vdel463, and V637M) and from 7 patients bearing 6 previously unidentified heterozygous mutations (N472D, S614G, T708N, K709E, V713M, and T714I).…”
Section: Discussionmentioning
confidence: 99%
“…Since 2007, up to 230 STAT3-deficient patients have been reported in individual case reports [2–4,13, 33, 35, 41, 43, 44, 55, 61, 68, 71] or national or international series, including 8 patients (Japan), [47] 37 (United States and Europe), [60] 12 (Lebanon and Europe), [29] 50 (international), [28] 64 (international), [70] and 48 patients (international). [62] However, most reports have focused on the molecular and cellular defects of the patients, providing little clinical information.…”
Section: Introductionmentioning
confidence: 99%
“…22 Both microdeletions involving this gene and deleterious mutations in DOCK8 were found in 21 patients with AR-HIES, a syndrome characterized by recurrent pneumonia, skin abscesses and viral infections (especially molluscum contagiosum and herpes viruses), very high eosinophilia and elevated serum IgE level, but, in contrast to the autosomal dominant form, does not present with skeletal or dental disease. Kim and colleagues23 reported a missense mutation in the linker domain of the signal transducer and activator of transcription 3 (STAT3) in a patient with autosomal dominant HIES, expanding the range of genetic defects causing this syndrome, since previous reports had found mutations in either the DNA-binding domain transactivation domain or the SH2 domain. Of note, this 5 year-old boy did not have any skeletal or dental anomalies.…”
Section: Primary Immunodeficiencies (Pid)mentioning
confidence: 99%